OPKO Health, Inc. – Product Pipeline Review – H2 2011

OPKO Health, Inc. - Product Pipeline Review - H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “OPKO Health, Inc. - Product Pipeline Review - H2 2011” provides data on the OPKO Health, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, OPKO Health, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from OPKO Health, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

• OPKO Health, Inc. - Brief OPKO Health, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
• Review of current pipeline of OPKO Health, Inc. human therapeutic division.
• Overview of pipeline therapeutics across various therapy areas.
• Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
• Product profiles for late stage and clinical stage products of OPKO Health, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
• Recent updates of the OPKO Health, Inc.’s pipeline in the last quarter.
• Key discontinued and dormant projects.
• Latest news and deals relating to the products.

Reasons to buy

• Evaluate OPKO Health, Inc.’s strategic position with total access to detailed information on its product pipeline.
• Assess the growth potential of OPKO Health, Inc. in its therapy areas of focus.
• Identify new drug targets and therapeutic classes in the OPKO Health, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
• Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
• Exploit collaboration and partnership opportunities with OPKO Health, Inc..
• Avoid Intellectual Property Rights related issues.
• Explore the dormant and discontinued projects of OPKO Health, Inc. and identify potential opportunities in those areas.